Dr. Thayer Nasereddin, MD

Dr. Nasereddin practices at The Endoscopy Center at St. Francis in Indianapolis, Indiana.

Dr. Nasereddin's NPI, 1215391701, was assigned on April 11, 2016. Dr. Nasereddin holds Indiana license 01087422A.

Dr. Nasereddin's primary practice is The Endoscopy Center at St. Francis, at 8051 S Emerson Ave Ste 150, Indianapolis, IN 46237. The practice phone is (317) 865-2955.

Dr. Nasereddin's primary practice is The Endoscopy Center at St. Francis in Indianapolis, Indiana. Dr. Nasereddin is also affiliated with Franciscan Health Indianapolis. The medical group on file is Parkview Physicians Group. Dmand AI also links Dr. Nasereddin to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nasereddin practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Nasereddin's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Nasereddin is licensed in Indiana.

CMS data shows 599 Medicare services from Dr. Nasereddin across 17 procedure codes in 2024, for 345 Medicare patients. Medicare paid $56,961 for them.

CMS counts 345 Medicare patients who saw Dr. Nasereddin in 2024. The largest group is 65 to 74, with 163 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nasereddin's median patient age at 61, with 56% women.

In 2024, Dr. Nasereddin wrote 669 Medicare Part D claims for 219 patients. 91% of them were for generic drugs. CMS names the drug for 523 of them, across 10 drugs with 11 or more claims each, at $25,481 in total drug cost. In 2023, CMS named 46 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Nasereddin for performance year 2024, reported as part of a group. Dr. Nasereddin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 366 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Nasereddin, more than 97% of the clinicians it reports for that procedure.

CMS Open Payments shows 160 general payments to Dr. Nasereddin from 28 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 84% of the total. Abbvie Inc. paid the most, $1,083.